Generation of a common European database and biobank Continous assessment and implementation of guidelines and treatment protocols Establishment of a large observational cohort of chILD patients Determination the value of outcomes used in child Assess treatment variations used, deliver data from defined protocols and linked outcomes
all children with suspected or
verified diagnosis of ILD or
masquerading as ILD and
those with rare localized parenchymal lung diseases
other indication as inclusion criteria
400 prevalent patients with childhood interstitial lung disease (chILD) in Europe 100 incident chILD cases per year
Case-only
Prospective
Not listed
Included subjects with specific diagnosis
Number of recruited subjects
Survial
Survival of the participants
Click on the lead sponsor to view all of their trials.
Matthias Griese
Lead sponsor
Ludwig-Maximilians - University of Munich
Sponsor institution
